Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 5R01DK058702-12
Nonintegrating Lentiviral Vectors Towards Clinical Trials
National Institutes of Health
Grant: 5P01HL112761-03
ANIMAL MODELS CORE
National Institutes of Health
Grant: 1RC3HL103396-01
Self-Complementary AAV2 Factor IX for Hemophilia B
National Institutes of Health
Grant: 5P01HL066973-05
Gene Therapy Pulmonary &Hematologic Disorders
Fields of Study
Keywords
Sustainable Development Goals